Ondansetron Kabi 0.16 mg / ml solution for infusion

Licence status
Authorised: 10/06/2022
Active substances
Ondansetron hydrochloride dihydrate
Dosage Form
Solution for infusion
Licence number
PA2059/080/002
Licence holder
Fresenius Kabi Deutschland GmbH

Product documents

Licence information

ATC code
A04AA01 ondansetron
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
10/06/2022